News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
65,749 Results
Type
Article (2844)
Company Profile (16)
Press Release (62889)
Section
Business (26443)
Career Advice (65)
Deals (3820)
Drug Delivery (3)
Drug Development (8098)
Employer Resources (4)
FDA (1572)
Job Trends (1695)
News (38429)
Policy (2484)
Tag
Academia (156)
Accelerated approval (2)
Allergies (16)
Alliances (2410)
ALS (24)
Alzheimer's disease (184)
Antibody-drug conjugate (ADC) (34)
Approvals (1695)
Artificial intelligence (30)
Autoimmune disease (13)
Automation (3)
Bankruptcy (16)
Best Places to Work (1630)
Biosimilars (14)
Biotechnology (9)
Bladder cancer (50)
Brain cancer (7)
Breast cancer (127)
Cancer (812)
Cardiovascular disease (69)
Career advice (52)
Career pathing (1)
CAR-T (33)
CDC (1)
Cell therapy (66)
Cervical cancer (10)
Clinical research (7736)
Collaboration (93)
Company closure (2)
Compensation (74)
Complete response letters (3)
COVID-19 (300)
CRISPR (6)
C-suite (34)
Cystic fibrosis (12)
Data (1051)
Depression (9)
Diabetes (74)
Diagnostics (731)
Digital health (3)
Diversity (1)
Drug discovery (9)
Drug pricing (5)
Drug shortages (1)
Duchenne muscular dystrophy (19)
Earnings (23961)
Editorial (3)
Employer branding (1)
Employer resources (4)
Events (6219)
Executive appointments (38)
FDA (2136)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (1)
Frontotemporal dementia (7)
Funding (72)
Gene editing (10)
Generative AI (2)
Gene therapy (36)
GLP-1 (96)
Government (369)
Grass and pollen (2)
Guidances (241)
Healthcare (2037)
HIV (9)
Huntington's disease (2)
IgA nephropathy (16)
Immunology and inflammation (20)
Immuno-oncology (4)
Indications (21)
Infectious disease (333)
Inflammatory bowel disease (10)
Influenza (12)
Intellectual property (12)
Interviews (5)
IPO (2791)
Job creations (160)
Job search strategy (43)
JPM (2)
Kidney cancer (5)
Labor market (4)
Layoffs (26)
Leadership (1)
Legal (345)
Liver cancer (5)
Lung cancer (126)
Lymphoma (95)
Machine learning (2)
Management (1)
Manufacturing (35)
MASH (22)
Medical device (1670)
Medtech (1679)
Mergers & acquisitions (1118)
Metabolic disorders (159)
Multiple sclerosis (30)
NASH (2)
Neurodegenerative disease (33)
Neuropsychiatric disorders (8)
Neuroscience (307)
NextGen: Class of 2026 (625)
Non-profit (366)
Now hiring (3)
Obesity (61)
Opinion (15)
Ovarian cancer (25)
Pain (11)
Pancreatic cancer (20)
Parkinson's disease (28)
Partnered (1)
Patents (32)
Patient recruitment (22)
Peanut (10)
People (1898)
Pharmaceutical (5)
Pharmacy benefit managers (5)
Phase 1 (1534)
Phase 2 (2904)
Phase 3 (3687)
Pipeline (1379)
Policy (12)
Postmarket research (367)
Preclinical (508)
Press Release (2)
Prostate cancer (41)
Psychedelics (2)
Radiopharmaceuticals (26)
Rare diseases (84)
Real estate (279)
Recruiting (2)
Regulatory (2239)
Reports (7)
Research institute (132)
Resumes & cover letters (19)
Rett syndrome (6)
RNA editing (1)
RSV (14)
Schizophrenia (13)
Series A (9)
Series B (6)
Sickle cell disease (10)
Special edition (4)
Spinal muscular atrophy (13)
Sponsored (1)
Startups (189)
Stomach cancer (3)
Supply chain (4)
Tariffs (7)
The Weekly (2)
Vaccines (89)
Venture capital (4)
Weight loss (33)
Women's health (8)
Worklife (1)
Date
Today (10)
Last 7 days (67)
Last 30 days (193)
Last 365 days (4264)
2026 (251)
2025 (4315)
2024 (4647)
2023 (4927)
2022 (5540)
2021 (6004)
2020 (5469)
2019 (4364)
2018 (3508)
2017 (3018)
2016 (2174)
2015 (2797)
2014 (1964)
2013 (1348)
2012 (1428)
2011 (1720)
2010 (1567)
Location
Africa (52)
Alabama (6)
Arizona (38)
Arkansas (1)
Asia (3598)
Australia (483)
California (1458)
Canada (407)
China (126)
Colorado (82)
Connecticut (60)
Delaware (81)
Europe (9718)
Florida (233)
Georgia (43)
Idaho (10)
Illinois (101)
India (11)
Indiana (87)
Iowa (1)
Japan (75)
Kansas (9)
Kentucky (8)
Louisiana (8)
Maine (42)
Maryland (118)
Massachusetts (1022)
Michigan (32)
Minnesota (140)
Missouri (10)
Montana (2)
Nebraska (1)
Nevada (13)
New Hampshire (8)
New Jersey (545)
New York (347)
North Carolina (161)
Northern California (793)
Ohio (24)
Oregon (3)
Pennsylvania (298)
Puerto Rico (1)
South America (69)
South Carolina (3)
Southern California (550)
Tennessee (15)
Texas (253)
United States (5335)
Utah (55)
Virginia (19)
Washington D.C. (4)
Washington State (128)
Wisconsin (9)
65,749 Results for "95".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Context Therapeutics Highlights CT-95 and CT-202 Programs at 2025 SITC Annual Meeting
November 10, 2025
·
5 min read
Press Releases
Cancer Immunotherapy Market Size to Hit USD 700.09 Billion by 2034, Growing at a Stellar 11.95% CAGR
December 1, 2025
·
1 min read
Press Releases
Excelsior Sciences Raises $95 Million to Transform Small Molecule Discovery and Manufacturing with Novel Chemistry that Machines Can Do
December 3, 2025
·
7 min read
Press Releases
Shield CRC Blood Test Demonstrates Adherence of 95% in New Study of 20,000 Patients
November 5, 2025
·
5 min read
Opinion
The GLP-1 Paradox—Why Is a $95B Obesity Market Ignoring Its Biggest Problem?
The nausea and other gastrointestinal side effects of weight loss drugs like Novo Nordisk’s Wegovy or Eli Lilly’s Zepbound will limit how much these drugs can help patients and stunt the overall obesity market unless we approach the problem head on.
November 7, 2025
·
5 min read
·
James O’Mara
Press Releases
AVS Announces Positive Safety and Effectiveness Data in First 95 Patients Treated in Pulse IVL IDE Study
November 4, 2025
·
3 min read
Press Releases
Valneva Reports 95% Seroresponse Four Years After Single Shot of Chikungunya Vaccine IXCHIQ®
September 30, 2025
·
6 min read
Mergers & acquisitions
Just 9.5% of Life Sciences M&A Milestones Have Been Paid Since 2008
A new analysis from SRS Acquiom puts into perspective the headline values seen when a company announces a backloaded M&A deal. Biotechs have much on the line when they agree to deals with massive potential but little upfront.
October 1, 2025
·
2 min read
·
Annalee Armstrong
Press Releases
Sparrow Pharmaceuticals Announces $95 Million Series B Financing to Advance Targeted Therapy for Type 2 Diabetes
September 25, 2025
·
6 min read
Press Releases
Trogenix announces £70 million / $95 million Series A financing to drive clinical development of potentially curative therapies for aggressive cancers
October 6, 2025
·
6 min read
1 of 6,575
Next
